Chelsea Therapeutics (NASDAQ: CHTP) left investors stunned today after taking a steep tumble. Shares dropped almost 30% after the Food and Drug Administration (FDA) posted briefing documents ahead of an advisory committee meeting for Chelsea's drug Northera. The meeting is scheduled for next week, but what did the market see in today's release? Analysts David Williamson and Max Macaluso discuss the details in the video below.
S&P 500
5,963.32
+0.5%
+$27.38
DJI
42,436.33
+0.3%
+$130.85
NASDAQ
19,387.81
+0.8%
+$145.20
Bitcoin
106,737.00
+2.2%
+2,329.75
AAPL
$202.44
+0.4%
+$0.74
AMZN
$206.81
+0.1%
+$0.16
GOOG
$168.73
-1.0%
-$1.64
META
$666.39
-0.7%
-$4.51
MSFT
$462.38
+0.1%
+$0.41
NVDA
$141.39
+2.9%
+$4.01
TSLA
$350.51
+2.3%
+$7.82
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.